article thumbnail

Enterprise Partners Portfolio Firm Heads Towards IPO

socalTECH

One of the portfolio firms of San Diego venture capital firm Enterprise Partners is heading towards an IPO, according to a S-1 filing Friday. The firm's other venture backers are Essex Woodlands Health Ventures, OrbiMed Advisors, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management.

article thumbnail

Enterprise Partners Re-Ups On Complete Genomics

socalTECH

San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Tags: illumina lifescience investment gene sequencing capital venture genomics complete partners enterprise.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Enterprise Partners Portfolio Firm Heads To Market

socalTECH

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Enterprise Partners owns about 14.8 According to a filing from Complete Genomics, it will sell 6 million shares at $9.00

article thumbnail

Celladon Gets $53M In Funding

socalTECH

The round came from new investors MPM Capital and LSP Life Sciences, along with Pfizer Venture Investors, Lundbeckfond Ventures, Novartis Venture Funds, Hambrecht and Quist Capital Management, GBS Venture Partners, Enterprise Partners Venture Capital, Johnson & Johnson Development Corp., and Venrock.

Funding 145
article thumbnail

Opthonix Sees $5.39M More

socalTECH

Opthonix is venture backed by Cross Creek Capital, DAG Ventures, Enterprise Partners, Gund Investment Corp., Interwest Partners, Kleiner Perkins Caufield and Byers, Palo Alto Investors, Trex Enterprises, and Wasatch Advisors. Opthonix sells is high resolution lenses under the iZon brand name.

article thumbnail

Southern California Investments On Uptick, Totals $686.5M For Q1

socalTECH

Southern California venture capital investments totaled $686.5M in 29 venture capital deals for Q1. Tags: venture capital financing investment quarterly moneytree nvca. According to the report, released today, Southern California investments totaled $686.5M received in the region in Q1 of 2009. across 31 days.

article thumbnail

Celladon Files For IPO

socalTECH

Celladon is backed by Enterprise Partners, Pfizer, Lundbeckfond, Novartis Bioventures, J&J Development, GBS Bioventures, MPM Capital, Venrock, H&Q, as well as others. The company''s IPO is being underwritten by J.P. Morgan, Barclays, Stifel, and Wedbush PacGrow Life Sciences.